Prognostic and therapeutic factors influencing the clinical outcome of metastatic Ewing sarcoma family of tumors: A retrospective report from the Japan Ewing Sarcoma Study Group
Katsutsugu Umeda(Kyoto University), Kenji Yamada(Oldham Council), Naoko Maeda(Nagoya Medical Center), Minako Sumi(Tokyo Metropolitan Geriatric Hospital), Hiroyuki Fujisaki(Osaka City General Hospital), Motoaki Chin(Nihon University), Takako Miyamura(The University of Osaka), Atsuko Watanabe(Saitama International Medical Center), Hideki Sano(Toho University), Yosuke Hosoya(St. Luke's International Hospital), Ryoji Jyoko(Okayama University), Daiichiro Hasegawa(Kobe Children's Hospital), Ako Hosono(National Cancer Center Hospital East), Satoshi Takenaka(Osaka International Cancer Institute), Hajime Okita(Keio University), Shunsuke Nakagawa(Kagoshima University), Toshifumi Ozaki(Okayama University), Takuya Kamio(Hirosaki University Hospital)
Cited by 9
Related Papers
Osteosarcoma of the Pelvis: Experience of the Cooperative Osteosarcoma Study Group
|Journal of Clinical Oncology|2003|344
Osteosarcoma of the spine
|Cancer|2002|282
Percutaneous radiofrequency ablation in osteoid osteoma
|Journal of Bone and Joint Surgery - British Volume|2001|267
CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment
|Molecular Cancer Therapeutics|2021|258
Clinical Assessment and Mutation Analysis of Kallmann Syndrome 1 (<i>KAL1</i>) and Fibroblast Growth Factor Receptor 1 (<i>FGFR1</i>, or<i>KAL2</i>) in Five Families and 18 Sporadic Patients
|The Journal of Clinical Endocrinology & Metabolism|2004|220